Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Cancer Lett ; 217(2): 231-6, 2005 Jan 20.
Artigo em Inglês | MEDLINE | ID: mdl-15617841

RESUMO

The expression of the c-kit protooncogene in human hepatocellular carcinoma (HCC) was investigated. Immunohistochemical staining (IHC) and RT-PCR were employed to examine the protein and mRNA expression of c-kit protooncogene, respectively. IHC results demonstrated that 22 of 86 (25.6%) HCC tissue sections expressed c-kit protein. The c-kit mRNA transcript was further confirmed in all 22 IHC c-kit positive HCC tissue samples by RT-PCR. Moreover, the relationship between c-kit expression in HCC and prognosis of patients was statistically analyzed and a correlation was established. The group of patients whose HCC specimens showed positive c-kit staining exhibited better survival as compared to those patients with negative c-kit expression (p=0.021). These results suggest that c-kit expression may be a good prognostic indicator for HCC.


Assuntos
Biomarcadores Tumorais/análise , Carcinoma Hepatocelular/metabolismo , Neoplasias Hepáticas/metabolismo , Proteínas Proto-Oncogênicas c-kit/biossíntese , Carcinoma Hepatocelular/mortalidade , Humanos , Imuno-Histoquímica , Neoplasias Hepáticas/mortalidade , Prognóstico , RNA Mensageiro/análise , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Análise de Sobrevida
2.
Platelets ; 15(7): 451-4, 2004 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-15745317

RESUMO

Idiopathic or immune thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by low platelet count resulting from antibody-mediated destruction of platelets. The production of these IgG anti-platelet autoantibodies is critically governed by T-lymphocytes which can be activated by antigen-presenting cells (APC) such as dendritic cells. We hypothesized that one of the mechanisms by which corticosteroid administration can suppress the immune system is to depress the number of circulating dendritic cells production in ITP patients. Dendritic cell population was measured in peripheral blood of three ITP patients before and after the administration of prednisone. Both counts of myeloid and lymphoid dendritic cells in the blood of ITP patients were greatly reduced after the administration of prednisone. The decrease in circulating dendritic cells is associated with the increase of platelets in circulation with the treatment of prednisone. These results suggest that corticosteroid therapy may decrease the effects of the autoantibody on platelets in ITP patients by reduce the number of circulating dendritic cells.


Assuntos
Formação de Anticorpos/efeitos dos fármacos , Autoanticorpos/imunologia , Células Dendríticas/imunologia , Glucocorticoides/administração & dosagem , Prednisolona/administração & dosagem , Púrpura Trombocitopênica Idiopática/imunologia , Adulto , Idoso , Formação de Anticorpos/imunologia , Plaquetas , Contagem de Células , Feminino , Humanos , Ativação Linfocitária/genética , Ativação Linfocitária/imunologia , Pessoa de Meia-Idade , Púrpura Trombocitopênica Idiopática/tratamento farmacológico , Linfócitos T/imunologia
3.
Leuk Lymphoma ; 44(6): 1059-61, 2003 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-12854910

RESUMO

Acute promyelocytic leukemia (APL) is characterized by severe bleeding associated with coagulation abnormalities. High incidence of disseminated intravascular coagulation (DIC) in APL often causes early hemorrhagic death. We report a case of APL with massive cerebral hemorrhage and respiratory failure in a 24-year old woman. A combination of all-trans retinoic acid (ATRA) differential therapy and blood component therapy was given to control DIC and stop bleeding. In order to minimize the severity of DIC during chemotherapy induced acute cytolysis, ATRA was started 8 days before the induction chemotherapy which consisted of idarubicin (IDA) and cytosine arabinoside (Ara-C). Complete clinical remission was achieved in this APL patient despite of the severity of the hemorrhage.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico , Hemorragia Cerebral/complicações , Hemorragia Cerebral/tratamento farmacológico , Leucemia Promielocítica Aguda/complicações , Leucemia Promielocítica Aguda/tratamento farmacológico , Tretinoína/uso terapêutico , Adulto , Hemorragia Cerebral/diagnóstico por imagem , Citarabina/administração & dosagem , Feminino , Humanos , Idarubicina/administração & dosagem , Leucemia Promielocítica Aguda/diagnóstico por imagem , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Tomografia Computadorizada por Raios X , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...